Suggestions
Guide for authors
Searcher
Journal Information
Vol. 41. Issue 11.
Pages 641 (November 2005)
Letters to the Editor
Full text access

Corticosteroids in Exacerbations of Chronic Obstructive Pulmonary Disease: Yes, but Less

Visits
4702
H. Verea-Hernández
Servicio de Neumología, Hospital Juan Canalejo, La Coruña, Spain
This item has received
Article information
Full text is only available in PDF
REFERENCES
[1]
M Carrera, E Sala, BG Cosío, AG Agustí.
Tratamiento hospitalario de los episodios de agudización de la EPOC. Una revisión basada en la evidencia.
Arch Bronconeumol, 41 (2005), pp. 220-229
[2]
L Davies, RM Angus, PMA Calverley.
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised trial.
Lancet, 354 (1999), pp. 456-460
[3]
SD Aaron, KL Vandemheen, P Hebert, R Dales, IG Stiell, J Ahuja, et al.
Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.
N Engl J Med, 348 (2003), pp. 2618-2625
[4]
LJ Walsh, CA Wong, J Oborne, S Cooper, M Pringue, R Hubbard, et al.
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.
Thorax, 56 (2001), pp. 279-284
[5]
CE Bolton, AA Ionescu, KM Shiels, RJ Pettit, PH Edwards, MD Stone, et al.
Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 170 (2004), pp. 1286-1293
[6]
F de Vries, TP van Staa, MS Bracke, C Cooper, HG Leufkens, JW Lammers.
Severity of obstructive airway disease and risk of osteoporotic fractures.
Eur Respir J, 25 (2005), pp. 879-884
[7]
EF Dubois, E Roder, R Dekhuijzen, AE Zwinderman, DH Schweizer.
Dual energy x-ray absorptiometry outcomes in male COPD patients after treatments with different glucocorticoid regimens.
Chest, 121 (2002), pp. 1456-1463
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools